These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11101184)

  • 41. Protamine allergy as a complication of insulin hypersensitivity: A case report.
    Bollinger ME; Hamilton RG; Wood RA
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):462-5. PubMed ID: 10452772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
    Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
    Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?
    Griffin ME; Feder A; Tamborlane WV
    Diabetes Care; 2001 Jan; 24(1):174. PubMed ID: 11194227
    [No Abstract]   [Full Text] [Related]  

  • 44. Systemic allergic reaction by a human insulin analog.
    Barranco R; Herrero T; Tornero P; Barrio M; Frutos C; Rodríguez A; Malvetti V; Luisa Baeza M
    Allergy; 2003 Jun; 58(6):536-7. PubMed ID: 12757463
    [No Abstract]   [Full Text] [Related]  

  • 45. Allergy to insulin in a woman with gestational diabetes mellitus: transient efficiency of continuous subcutaneous insulin lispro infusion.
    Durand-Gonzalez KN; Guillausseau N; Anciaux ML; Hentschel V; Gayno JP
    Diabetes Metab; 2003 Sep; 29(4 Pt 1):432-4. PubMed ID: 14526273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Insulin allergy in type II diabetes: rapid desensitization].
    Ruíz Barrera E; Martínez-Cario Cueto S
    Rev Alerg Mex; 1994; 41(1):19-24. PubMed ID: 8087231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-acting insulin allergy in a diabetic child.
    Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review.
    Elfekih H; Hadjkacem F; Elleuch M; Ghorbel D; Charfi N; Mnif F; Rekik N; Mnif M; Abid M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):572-583. PubMed ID: 32245301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic decompensation in pump users due to lispro insulin precipitation.
    Wolpert HA; Faradji RN; Bonner-Weir S; Lipes MA
    BMJ; 2002 May; 324(7348):1253. PubMed ID: 12028980
    [No Abstract]   [Full Text] [Related]  

  • 50. A new case of lipoatrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?
    Ampudia-Blasco FJ; Hasbum B; Carmena R
    Diabetes Care; 2003 Mar; 26(3):953-4. PubMed ID: 12610070
    [No Abstract]   [Full Text] [Related]  

  • 51. Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin.
    Kara C; Kutlu AO; Evliyaoglu O; Bilgili H; Yildirim N
    Diabetes Care; 2005 Apr; 28(4):983-4. PubMed ID: 15793215
    [No Abstract]   [Full Text] [Related]  

  • 52. Generalized allergy due to zinc in insulin treated with zinc-free insulin.
    Ben Ammar I; Ksouri H; Trabelsi N; Mellouli F; Ben Mami F; Dakhli S; Achour A
    Acta Diabetol; 2012 Jun; 49(3):239-41. PubMed ID: 20963448
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient.
    Silva ME; Mendes MJ; Ursich MJ; Rocha DM; Brito AH; Fukui RT; Ruggeri GB; Nery M; Wajchenberg BL
    Diabetes Res Clin Pract; 1997 May; 36(2):67-70. PubMed ID: 9229189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intradermal desensitization with human insulin (recombinant DNA) in a patient with severe allergic skin reaction due to insulin.
    Bachmann W; Hasche H; Mehnert H
    Diabetes Care; 1982; 5 Suppl 2():165-7. PubMed ID: 6765529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Desensitization for insulin allergy: a useful treatment also for local forms.
    Eguíluz-Gracia I; Rodríguez-Alvarez M; Cimarra-Alvarez M; Sanabria-Pérez MC; Martínez-Cócera C
    J Investig Allergol Clin Immunol; 2012; 22(3):215-6. PubMed ID: 22697012
    [No Abstract]   [Full Text] [Related]  

  • 56. Vitiligo associated with subcutaneous insulin lispro infusion in type 1 diabetes.
    Burge MR; Carey JD
    Diabetes Care; 2004 Jan; 27(1):275-6. PubMed ID: 14694005
    [No Abstract]   [Full Text] [Related]  

  • 57. [Insulin-induced lipoatrophy in children].
    Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
    Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of insulin allergy after bone marrow transplantation.
    Yoshida N; Okubo M; Ishiguro K; Mori Y
    Diabet Med; 2012 Oct; 29(10):1339-41. PubMed ID: 22587424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment with continuous subcutaneous insulin infusion for allergy to human insulin and its analogs.
    Zhang L; Zhang M; Liu YY; Hu M; Zhou X; Luo Y
    Diabetes Res Clin Pract; 2011 Oct; 94(1):e1-2. PubMed ID: 21742397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glargine insulin is not an alternative in insulin allergy.
    Durand-Gonzalez KN; Guillausseau N; Pecquet C; Gayno JP
    Diabetes Care; 2003 Jul; 26(7):2216. PubMed ID: 12832347
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.